Scientists may have found possible targets for therapeutic interventions in the fight against Lou Gehrigs disease. A research team conducted the first single-molecule study of folding in the protein superoxide dismutase-1 (SOD1), an antioxidant whose misfolding is linked to the neurodegenerative disease ALS. They found that it has much more complex folding than previously thought.
Please check the official event website for possible changes before you make any travel arrangements.
Prices are for evaluation only.